# Huzhou Arthur Pharmaceutical Co., Ltd. – FDA Inspection, Sep 23, 2025

Source: https://www.keypedia.com/records/fda_inspections/huzhou-arthur-pharmaceutical-co-ltd/4efc787d-b1ad-4212-80ab-00e032c789cf
Source feed: FDA_Inspections

> FDA inspection 1288564 of Huzhou Arthur Pharmaceutical Co., Ltd., September 23, 2025. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288564
- Company Name: Huzhou Arthur Pharmaceutical Co., Ltd.
- Inspection Date: 2025-09-23
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- [FDA Inspection 1337514 - 2026-09-22](https://www.keypedia.com/records/fda_inspections/huzhou-arthur-pharmaceutical-co-ltd/a2964c67-7ff0-4658-b32d-4665befa10ab)
- FDA Inspection 1328918 - 2026-06-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/huzhou-arthur-pharmaceutical-co-ltd/6bb5af56-f8a9-4b6b-883e-b70d30a47960

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8